trending Market Intelligence /marketintelligence/en/news-insights/trending/NQFMHQBgPFkhUWebQ4M0Sw2 content esgSubNav
In This List

IBio regains compliance with NYSE American's listing standards

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


IBio regains compliance with NYSE American's listing standards

NYSE American LLC informed iBio Inc. that the company had regained compliance with all of the stock exchange's listing standards.

The New York-based biotechnology company received a noncompliance notice in June after its stockholders' equity fell below the exchange's minimum requirement of $6 million and it booked net losses in five of its most recent fiscal years.

In August, NYSE American accepted iBio's plan to regain compliance with the stock exchange, which had a deadline of Dec. 6, 2019.

IBio provides product development and manufacturing services to clients, collaborators, and third-party customers.